Tìm kiếm
Abeona Therapeutics Inc
ABEOThêm vào danh sách theo dõi
5.430USD
-0.100-1.81%
Đóng cửa 09-24 16:00（ET）
309.51MVốn hóa
4.24P/E TTM
Giới thiệu về Abeona Therapeutics Inc Công ty
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. The Company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa. Its fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. Its development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Its AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. Its pipeline programs include ABO-504 (Stargardt disease), ABO-503 (X-linked retinoschisis), ABO-505 (autosomal dominant optic atrophy), UX111 (Sanfilippo Syndrome Type A (MPS IIIA)), TSHA-102 (Rett Syndrome), and TSHA-118 (Infantile Batten Disease (CLN1 Disease)).
Abeona Therapeutics Inc Hồ sơ
Mã chứng khoánABEO
Tên công tyAbeona Therapeutics Inc
Ngày IPOSep 19, 1980
Giám đốc điều hànhSeshadri (Vishwas)
Số lượng nhân viên136
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhSep 19
Địa chỉ6555 Carnegie Ave, 4th Floor
Thành phốCLEVELAND
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaUnited States of America
Mã bưu điện44103
Điện thoại16468134701
Trang webhttps://abeonatherapeutics.com/
Mã chứng khoánABEO
Ngày IPOSep 19, 1980
Giám đốc điều hànhSeshadri (Vishwas)
Lãnh đạo công ty của Abeona Therapeutics Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Mr. Michael Amoroso
Mr. Michael Amoroso
Chairman of the Board
Chairman of the Board
217.78K
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Abeona Therapeutics Inc?
Năm cổ đông hàng đầu của Abeona Therapeutics Inc là: Dr. Vishwas (Vish) Seshadri, Ph.D.
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Abeona Therapeutics Inc (ABEO)?
Tính đến ngày 2026Q1, có 221 tổ chức nắm giữ cổ phiếu của Abeona Therapeutics Inc, với tổng giá trị thị trường khoảng 40.30M, chiếm 70.85% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -6739269.00.